|
Nov 10, 2025 |
IMDX Reports Q3 2025 Results and Progress Toward 2026 Commercial Launch
|
PDF
|
|
Nov 03, 2025 |
iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week
|
PDF
|
|
Oct 13, 2025 |
iMDx Welcomes New VP Marketing to Prepare for Commercial Transplant Assay Launch
|
PDF
|
|
Oct 06, 2025 |
iMDx Reports Kidney Transplant Patient Achieved ‘Immune Reset’ with Novel Therapy and GraftAssure Monitoring
|
PDF
|
|
Sep 24, 2025 |
Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando
|
PDF
|
|
Sep 08, 2025 |
Insight Molecular Diagnostics Announces Positive Strategic Update and Novel Registry Database
|
PDF
|
|
Sep 08, 2025 |
IMDX Enrolls First Patient in GraftAssureDx Clinical Trial and Welcomes New Hospital Participants
|
PDF
|
|
Aug 26, 2025 |
iMDx to Participate in NYC Investment Conferences September 8 - 11
|
PDF
|
|
Aug 11, 2025 |
IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch
|
PDF
|
|
Aug 04, 2025 |
iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference
|
PDF
|